ArticleCritical care (London, England)2008

The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.

Nalan Kayhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.